Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic
- PMID: 33521724
- PMCID: PMC7837007
- DOI: 10.1016/S2666-5247(20)30168-3
Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic
References
-
- Lim CY, Bohn MK, Lippi G. Staff rostering, split team arrangement, social distancing (physical distancing) and use of personal protective equipment to minimize risk of workplace transmission during the COVID-19 pandemic: a simulation study. Clin Biochem. 2020 doi: 10.1016/j.clinbiochem.2020.09.003. published online Sept 12. - DOI - PMC - PubMed
-
- Lim PL, Kurup A, Gopalakrishna G. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med. 2004;350:1740–1745. - PubMed
-
- Loh TP, Horvath AR, Wang CB. Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey. Clin Chem Lab Med. 2020;58:1433–1440. - PubMed
-
- Loh TP, Horvath AR, Wang CB. Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey. Clin Chem Lab Med. 2020;58:1441–1449. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical